AmbioPharm adds China capacity
Submitted by:
Andrew Warmington
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion
SK Pharmteco expands in small molecules, peptides
Submitted by:
Andrew Warmington
CDMO SK Pharmteco has announced plans to invest $260 million in a new small molecule
CordenPharma invests heavily in peptides
Submitted by:
Andrew Warmington
CordenPharma is to spend about €900 million over the next three years to expand its
PI bids for Plant Health Care
Submitted by:
Andrew Warmington
India’s PI Industries has agreed to acquire UK-based Plant Health Care (PHC), a specialist in
Almac doubles peptide capacity
Submitted by:
Andrew Warmington
Almac Group has announced the completion of two new purpose-built facilities at its headquarters in
CordenPharma expands early-phase peptides
Submitted by:
Andrew Warmington
CordenPharma has announced the commissioning of new GMP capacities at its Frankfurt site to manufacture
WuXi AppTec triples peptide capacity
Submitted by:
Andrew Warmington
In response to growing demand worldwide, WuXi AppTec has commissioned two new peptide plants, one
WuXi peptide expansion
Submitted by:
Andrew Warmington
WuXi STA has added two 2,000 L reactors and a large-scale continuous purification system for
New large-volume peptide deal for Bachem
Submitted by:
Andrew Warmington
Bachem has signed a new framework agreement to provide large volumes of peptides to an
$1 billion peptide deal announced
Submitted by:
Andrew Warmington
CordenPharma has signed a multi-year agreement for the contract manufacture of a large-volume launch peptide